Analgesic Effect of Resistance Training for Breast Cancer Survivors
- Conditions
- Breast CancerSurgeryChemotherapy EffectRadiotherapy Side EffectPain, Chronic
- Interventions
- Other: ControlOther: Training
- Registration Number
- NCT04509284
- Lead Sponsor
- Aalborg University
- Brief Summary
Persistent pain after treatment for breast cancer is a major clinical problem, affecting 25-60 % of the patients and is a source of considerable physical disability and psychological distress. Thus, the development of novel interventions to improve pain management for these patients is of clinical importance. Resistance training (RT) is a promising tool to combat a variety of undesirable adverse effects due to breast cancer treatment. Further, research suggests that it may also be able to provide pain-relieving benefits.
Hypothesis: Resistance training will improve pain perception and physical function in the short- and long term compared to a non-training control group.
- Detailed Description
Breast cancer is the most common cancer in women worldwide with more than a million new cases diagnosed every year \[1\]. Fortunately, due to better treatment options, the population of long-term survivors is increasing. This poses new demands for knowledge on how to manage late effects to the treatment regimen. Persistent pain after treatment for breast cancer is a common and underestimated problem as well as it can be a source of considerable physical disability and psychological distress \[2\]. Hence, the development of novel interventions to improve pain management is of high clinical relevance. Resistance training (RT) is a promising clinical therapeutic tool to improve a variety of adverse effects to breast cancer treatment \[3\] and may provide several pain-relieving benefits \[4\]. However, the efficacy of this modality for managing persistent pain after breast cancer treatment is currently unclear. Therefore, the purpose of this project is to investigate if individualized RT can modulate persistent pain after breast cancer treatment, thereby improving our understanding of how this modality may benefit patients and contribute to clinical guidelines for pain management in this clinical population.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 20
- primary diagnosis of breast cancer (grades I-IIIA).
- adult women at least 18 years of age.
- having received breast cancer treatment (i.e. surgery and possible adjuvant chemo and/or radiotherapy) at least 18 months before the start of the study.
- self reported pain in the areas of the breast, shoulder, axilla, arm and/or side of body with an intensity of ≥ 3 on a numeric rating scale (0 = no pain, 10 = worst pain imaginable).
- no signs of cancer recurrence.
- reading, writing and speaking Danish.
- breast surgery for cosmetic reasons or prophylactic mastectomy.
- bilateral breast cancer.
- lymphedema.
- other chronic pain conditions (e.g., rheumatoid arthritis).
- previous diagnosis of fibromyalgia syndrome.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Control Participants with persistent pain after breast cancer treatment will be instructed to continue their everyday lifestyle and be encouraged not to engage in new forms of exercise or physical activity throughout the study period. Training Training Participants with persistent pain after breast cancer treatment will receive 24 sessions of individualized progressive total body resistance training, supervised by a certified strength and conditioning specialist.
- Primary Outcome Measures
Name Time Method Change in pain sensitivity, assessed through pressure pain thresholds. Baseline and at 3, and 6 months Between group comparisons of treatment effect (change in pressure pain thresholds) from baseline to follow-up) will be performed. Pressure pain thresholds will be collected with a pressure algometer with a progressive increment in pressure of 30kPa.
Change in pain intensity, assessed through a 11 point numeric rating scale (0 = no pain, 10 = worst pain imaginable). Baseline and at 3, and 6 months Pain intensity is collected in two different contexts; 1) recollection for the past 3 months and 2) movement evoked pain during testing and training.
- Secondary Outcome Measures
Name Time Method Active shoulder range of motion assessed with a universal goniometer. Baseline and at 3, and 6 months Active range of motion for the affected shoulder is collected for shoulder flexion, horizontal shoulder flexion/extension, shoulder abduction and internal/external shoulder/rotation
Body composition assessed through bioelectrical impedance measurements. Baseline and at 3, and 6 months Estimates of body fat mass, fat free mass, skeletal muscle mass and bodyfat percentage are collected from bioelectrical impedance using an InBody370 device.
Arm circumference measured bilaterally at a single point 30cm above the styloid process. Baseline and at 3, and 6 months Arm circumference is collected to assess potential lymphedema development. A difference in circumference of \>10% between arms is considered indicative of lymphedema.
Physical activity level assessed through the international physical activity questionnaire (IPAQ). Baseline and at 3, and 6 months IPAQ estimates physical activity level as "low", "moderate" or "high" from the number of days and time per day conducting either hard, moderate or easy physical activity for the pas seven days.
Health related quality of life assessed through the European Organisation for Research and Treatment of Cancer (EORCT)-C30 quality of life questionaire Baseline and at 3, and 6 months The EORCT-C30 QLQ estimates quality of life through a series of questions regarding the extent to which the respondee experience various restrictions in physical function and well-being common in cancer patients, ranging from 1 (not at all) to 4 (A lot) on a four point likert scale.
Muscular strength assesses through a 1 repetition maximum (1RM) Baseline and at 3, and 6 months 1RM box squat, bench press, trapbar deadlift, bench pull and lat pulldown conducted in accordance with the recommendations of the American College of Sports Medicine (ACSM)
Quality of life assessed through the breast cancer specific European Organisation for Research and Treatment of Cancer (EORCT)-BR23 quality of life questionaire Baseline and at 3, and 6 months The EORCT-C30 QLQ estimates quality of life through a series of questions regarding the extent to which the respondee experience various restrictions in physical function and well-being common in breast cancer patients, ranging from 1 (not at all) to 4 (A lot) on a four point likert scale.
Cancer fatigue assessed through the Functional Assessment of Chronic Illness Therapy (FACIT) - fatigue scale. Baseline and at 3, and 6 months The FACIT-scale estimates fatigue through a series of questions regarding the extent to which the respondee experience various symptoms of fatigue, ranging from 0 (not at all) to 4 (A lot) on a five point likert scale.
Mental health assessed through the Major Depression Index (MDI) Baseline and at 3, and 6 months The MDI estimates mental health through a series of questions regarding the extent to which the respondee experience various symptoms of depression, ranging from 0 (never) to 5 (All the time) on a five point likert scale.
Trial Locations
- Locations (1)
Department of Health Science and Technology, Aalborg University
🇩🇰Aalborg, Northern Jutland, Denmark